MedTrace Logo

Surveillance and Tracking the Outcomes of Chronic Latent EBV Infection

NCT03491605 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2021-02-10

No results posted yet for this study

Summary

Immunocompetent subjects with high load of Epstein-Barr virus DNA (EBV-DNA) in peripheral blood will be enrolled and prospectively followed up to track the natural histories of the chronic high load of EBV virus. The primary goal of this study is to explore the association of peripheral high load of EBV with the hematological malignancies, and second goal is to investigate the genetic mechanisms of immune escape and tumorigenesis of chronic EBV infection.

Conditions

  • EBV Infection

Interventions

OTHER

peripheral EBV-DNA load

No intervention

Sponsors & Collaborators

  • Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • Jianfeng Zhou, PhD.and MD. · Director of Department of Hematology in Tongji Hospital，HUST

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2024-12-31
Completion
2029-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03491605 on ClinicalTrials.gov